E-cigarette Epidemic: Urgent Measures Needed in Scotland

Regulations by 2FIRSTS.ai
Dec.06.2023
E-cigarette Epidemic: Urgent Measures Needed in Scotland
Ash Scotland, a charity, reports that Scottish pediatric lung doctors describe student use of e-cigarettes as an "e-cigarette epidemic.

According to a charitable organization report by Ash Scotland, respiratory pediatricians in Scotland have described the widespread use of e-cigarettes among students as an "e-cigarette epidemic". This report supports proposals by the UK government and local authorities to restrict the flavors, packaging, and marketing of e-cigarettes, and urges further mitigation measures.

 

Chief executive of Scotland's anti-smoking campaign, Sheila Duffy, has expressed the need for swift and decisive action in the face of this public health challenge, in order to stem the rapid increase in the use of e-cigarettes among Scottish children and young people in recent years.

 

Children are lured by the flavors and scents of fruit and candy-flavored e-cigarettes, as well as the elaborate designs, packaging, and marketing tactics, especially for disposable products that are priced as low as £2. Considering that most e-cigarettes contain high levels of nicotine and toxic chemicals that are inhaled without proper safety testing, we propose removing all flavors, except for tobacco, from products that pose a health risk.

 

The agreement calls for a complete ban on disposable e-cigarettes. Over the past three years, the number of children using e-cigarettes has tripled, prompting the advisory panel to propose new measures. Evidence from the World Health Organization suggests that e-cigarettes could serve as a gateway to smoking, making young people more susceptible to nicotine addiction.

 

Hillary Duff further added, "We are also calling for a complete ban on the use of disposable e-cigarettes and implementing other stringent measures such as prohibiting the use of imagery, colors, and branding to minimize the appeal of these products to children, and concealing all e-cigarettes from the retail environment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Singapore detected 59 large-scale vape smuggling cases in 2025, seizing about 230,000 items
Singapore detected 59 large-scale vape smuggling cases in 2025, seizing about 230,000 items
Singapore’s Ministry of Health said on Feb. 3 that authorities detected 59 large-scale vape smuggling cases in 2025 and seized about 230,000 vapes and accessories. Over the past two years, more than 10,000 online vape sale advertisements were removed, with about 99% linked to overseas platform posts. Enforcement includes bot-driven surveillance, public tip-offs, and site-blocking with partner agencies.
Feb.04 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
UK OPSS launches vape safety campaign focusing on use, charging and disposal
UK OPSS launches vape safety campaign focusing on use, charging and disposal
The UK Office for Product Safety and Standards (OPSS) published information on March 4, 2026, launching a new campaign to raise awareness among young people about safety issues linked to using, charging and disposing of vapes.
Mar.06 by 2FIRSTS.ai
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
Special Report
Feb.23